Shijiazhuang Yiling Pharmaceutical announced that its wholly-owned subsidiary, wh group Pharmaceutical Co., Ltd., has received FDA approval for Simvastatin tablets. Simvastatin tablets are a lipid-lowering medication primarily used to reduce the risk of coronary heart disease-related mortality and improve dyslipidemia.
以岭药业:辛伐他汀片获得美国FDA批准
Shijiazhuang Yiling Pharmaceutical: Simvastatin tablets approved by the FDA in the USA.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.